Pharmaceutical News

RSS

New invaluable tool in drug manufacture

Drug companies could save millions thanks to a new technology to monitor crystals as they form.

8 Jun 2008

Arthritis drugs used in children to be investigated because of cancer link

Authorities in the United States are investigating certain types of drugs used to treat arthritis and other conditions.

5 Jun 2008

Survey shows Americans regard reducing the cost of prescription drugs as highest health care priority

In a national survey released today by the Alliance of Minority Medical Associations (AMMA), Americans noted that their highest health care priority is reducing the cost of prescription drugs. Furthermore, survey respondents shared overwhelming support for creating an approval pathway for generic, or follow-on biotechnology therapies, with 86% of likely voters stating their desire for such a system.

4 Jun 2008

Walgreens to pay $35 million to settle Medicaid prescription drug fraud allegations

Walgreen Co. of Deerfield, Ill., has agreed to pay $35 million to settle claims that from 2001 to 2005, it improperly switched patients to different versions of the prescriptions drugs Ranitidine, Fluoxetine and Eldepryl in order to increase its reimbursement from Medicaid, the Justice Department announced today.

4 Jun 2008

BN ImmunoTherapeutics starts clinical trials with prostate cancer vaccine

BN ImmunoTherapeutics, Inc. has initiated Phase I/II clinical studies with its therapeutic vaccine candidate against prostate cancer.

4 Jun 2008

Settlements between PBMs, States, indicate need for 'stronger medicine' to address problems, Lazarus writes

A $9.5 million settlement with 28 states announced last week by Express Scripts to resolve allegations that the company had "been pocketing money from pharmaceutical companies to steer patients into name-brand drugs" indicates the need for "some stronger medicine" to address problems in the industry, Los Angeles Times columnist David Lazarus writes.

3 Jun 2008

Most U.S. medical schools do not adequately limit gifts, payments from pharmaceutical industry, report finds

Most U.S. medical schools do not adequately limit gifts and payments from pharmaceutical companies to physicians and students, according to a report released on Tuesday by the American Medical Student Association, the New York Times reports.

3 Jun 2008

Boehringer Ingelheim, Gilead to freeze AIDS drug price

AIDS Healthcare Foundation (AHF) today applauded decisions by Boehringer Ingelheim (BI) and Gilead Sciences, Inc. to freeze prices on antiretroviral medications purchased by government agencies.

3 Jun 2008

Latest drug scare in China sees six dead

In the last 10 days six people have died in east China's Jiangxi province after being injected with human immunoglobulin at a hospital in the provincial capital Nanchang.

3 Jun 2008

Biopharmaceutical manufacturing capacity to increase 66% in Europe by 2012, sccording to new report

Production capacity for biopharmaceutical manufacturing will expand an average of 46% over the next five years for mammalian production systems, according to a new report by BioPlan Associates.

2 Jun 2008

Arana and Greenovation in anti-cancer co-development deal

Arana Therapeutics Limited and Germany-based greenovation Biotech GmbH have entered into a collaborative agreement to develop next generation anti-cancer antibodies.

2 Jun 2008

CMS launches campaign to enroll more low-income Medicare beneficiaries in prescription drug assistance program

CMS launched a $12 million outreach campaign last month to encourage low-income Medicare beneficiaries to enroll in the prescription drug assistance program, CongressDaily reports.

2 Jun 2008

Appeals court decisions in Vioxx lawsuits indicate 'sanity still exists' in legal system, editorial states

State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system -- at least at the appellate level," according to a Wall Street Journal editorial.

2 Jun 2008

Journal of Pharmaceutical Innovation publishes groundbreaking scientific papers

The first scientific papers outlining the progress made on the Product Quality Lifecycle Implementation (PQLI) initiative are being published in the June 2008 issue of the Journal of Pharmaceutical Innovation (JPI).

2 Jun 2008

New breast cancer drug combo shrinks aggressive tumours

An international trial of a new breast cancer drug has shown the drug is able to shrink tumours caused by one of the most aggressive forms of the disease.

2 Jun 2008

Peregrine Pharmaceuticals updates on Bavituximab breast cancer study

Peregrine Pharmaceuticals, Inc. has announced that results from a Phase I clinical trial of its lead anti-phosphatidylserine (anti-PS) antibody bavituximab in combination with chemotherapy in patients with advanced cancer were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.

2 Jun 2008

Mylan acquires generics businesses of Merck KGaA

Mylan Inc. today announced that it has acquired Merck KGaA's Central & Eastern Europe (CEE) generics businesses, which include operations in Poland, Hungary, Slovakia, Slovenia and the Czech Republic.

2 Jun 2008

Oncolytics Biotech announces results for intravenous Reolysin in patients with sarcomas metastatic to the lung

Oncolytics Biotech Inc. has announced that interim results of a Phase II study of intravenous Reolysin in patients with sarcomas metastatic to the lung were presented yesterday at the American Society of Clinical Oncology (ASCO) annual meeting.

2 Jun 2008

Medarex announces preliminary data for investigational anti-PD-1 antibody

Medarex, Inc. has announced preliminary data from an ongoing Phase 1 study of MDX-1106 (ONO-4538: development code of Ono Pharmaceutical Co., Ltd.), a fully human anti-PD-1 antibody.

2 Jun 2008

IDM Pharma presents new data on IDM-2101 in non-small cell lung cancer

IDM Pharma, Inc. today announced follow-up results from the Phase 2 study of IDM-2101 showing that the product candidate was well tolerated, induced broadly specific cytotoxic T lymphocyte (CTL) responses, and showed a positive survival trend in HLA-A2 positive patients with non-small cell lung cancer (NSCLC) who were treated with IDM-2101, compared to a parallel external control group of HLA-A2 negative non-treated patients.

2 Jun 2008

Pharmaceutical News

New invaluable tool in drug manufacture

Arthritis drugs used in children to be investigated because of cancer link

Survey shows Americans regard reducing the cost of prescription drugs as highest health care priority

Walgreens to pay $35 million to settle Medicaid prescription drug fraud allegations

BN ImmunoTherapeutics starts clinical trials with prostate cancer vaccine

Settlements between PBMs, States, indicate need for 'stronger medicine' to address problems, Lazarus writes

Most U.S. medical schools do not adequately limit gifts, payments from pharmaceutical industry, report finds

Boehringer Ingelheim, Gilead to freeze AIDS drug price

Latest drug scare in China sees six dead

Biopharmaceutical manufacturing capacity to increase 66% in Europe by 2012, sccording to new report

Arana and Greenovation in anti-cancer co-development deal

CMS launches campaign to enroll more low-income Medicare beneficiaries in prescription drug assistance program

Appeals court decisions in Vioxx lawsuits indicate 'sanity still exists' in legal system, editorial states

Journal of Pharmaceutical Innovation publishes groundbreaking scientific papers

New breast cancer drug combo shrinks aggressive tumours

Peregrine Pharmaceuticals updates on Bavituximab breast cancer study

Mylan acquires generics businesses of Merck KGaA

Oncolytics Biotech announces results for intravenous Reolysin in patients with sarcomas metastatic to the lung

Medarex announces preliminary data for investigational anti-PD-1 antibody

IDM Pharma presents new data on IDM-2101 in non-small cell lung cancer

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News